Bionoid Pharma, Inc.
Bionoid Pharma, Inc. (BINP) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
binp · pe ratio · data through Dec 31, 2024
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Bionoid Pharma, Inc. (BINP) measures how much investors pay for each dollar of the company's trailing earnings. BINP's current PE ratio of N/A is calculated by dividing its stock price of $0.03 by its TTM earnings per share of -$0.01.
Source: FMP · /ratios-ttm · /analyst-estimates · 2024-12-31
PE Ratio History
2006 – 2024 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Bionoid Pharma, Inc.You BINP | $2M | N/A | — | -$0.01 |
 BioTech Medics, Inc. BMCS | $0M | N/A | — | -$0.00 |
 Body and Mind Inc. BMMJ | $0M | N/A | — | -$0.16 |
 Target Group Inc. CBDY | $1M | N/A | — | -$0.00 |
 CTT Pharmaceutical Holdings, Inc. CTTH | $2M | N/A | — | -$0.00 |
 Endexx Corporation EDXC | $0M | N/A | — | -$0.01 |
 Anything Technologies Media, Inc. EXMT | $2M | N/A | — | -$0.00 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2024-12-31Latest FY2024 | — | $-0.01 | — | |
2023-12-31 FY2023 | 1666.58x | $0.00 | -96.4% | |
2022-12-31 FY2022 | — | $0.00 | — | |
2021-12-31 FY2021 | — | $-0.00 | — | |
2020-12-31 FY2020 | — | $-11.88 | — | |
2019-12-31 FY2019 | 9.15x | $0.71 | — | |
2013-12-31 FY2013 | — | $-46.37 | — | |
2011-12-31 FY2011 | — | $-335.25 | — | |
2010-12-31 FY2010 | — | $-0.13 | — | |
2009-12-31 FY2009 | — | $-0.16 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Bionoid Pharma, Inc. (BINP) measures how much investors pay for each dollar of the company's trailing earnings. BINP's current PE ratio of N/A is calculated by dividing its stock price of $0.03 by its TTM earnings per share of -$0.01.
Frequently asked questions
BINP pe ratio · 6 questionsBINP's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.03 and TTM EPS of -$0.01. Data sourced from Financial Modeling Prep via BINP's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Bionoid Pharma, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09